Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients

BackgroundFLASH radiotherapy (RT) is a novel method for delivering ionizing radiation, which has been shown in preclinical studies to have a normal tissue sparing effect and to maintain anticancer efficacy as compared to conventional RT. Treatment of head and neck tumors with conventional RT is comm...

Full description

Bibliographic Details
Main Authors: Betina Børresen, Maja L. Arendt, Elise Konradsson, Kristine Bastholm Jensen, Sven ÅJ. Bäck, Per Munck af Rosenschöld, Crister Ceberg, Kristoffer Petersson
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1256760/full
_version_ 1827820885644410880
author Betina Børresen
Maja L. Arendt
Elise Konradsson
Kristine Bastholm Jensen
Sven ÅJ. Bäck
Per Munck af Rosenschöld
Crister Ceberg
Kristoffer Petersson
Kristoffer Petersson
author_facet Betina Børresen
Maja L. Arendt
Elise Konradsson
Kristine Bastholm Jensen
Sven ÅJ. Bäck
Per Munck af Rosenschöld
Crister Ceberg
Kristoffer Petersson
Kristoffer Petersson
author_sort Betina Børresen
collection DOAJ
description BackgroundFLASH radiotherapy (RT) is a novel method for delivering ionizing radiation, which has been shown in preclinical studies to have a normal tissue sparing effect and to maintain anticancer efficacy as compared to conventional RT. Treatment of head and neck tumors with conventional RT is commonly associated with severe toxicity, hence the normal tissue sparing effect of FLASH RT potentially makes it especially advantageous for treating oral tumors. In this work, the objective was to study the adverse effects of dogs with spontaneous oral tumors treated with FLASH RT.MethodsPrivately-owned dogs with macroscopic malignant tumors of the oral cavity were treated with a single fraction of ≥30Gy electron FLASH RT and subsequently followed for 12 months. A modified conventional linear accelerator was used to deliver the FLASH RT.ResultsEleven dogs were enrolled in this prospective study. High grade adverse effects were common, especially if bone was included in the treatment field. Four out of six dogs, who had bone in their treatment field and lived at least 5 months after RT, developed osteoradionecrosis at 3-12 months post treatment. The treatment was overall effective with 8/11 complete clinical responses and 3/11 partial responses.ConclusionThis study shows that single-fraction high dose FLASH RT was generally effective in this mixed group of malignant oral tumors, but the risk of osteoradionecrosis is a serious clinical concern. It is possible that the risk of osteonecrosis can be mitigated through fractionation and improved dose conformity, which needs to be addressed before moving forward with clinical trials in human cancer patients.
first_indexed 2024-03-12T01:34:22Z
format Article
id doaj.art-98da175dc7d74a7b9d3b581169f61e4a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-03-12T01:34:22Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-98da175dc7d74a7b9d3b581169f61e4a2023-09-11T12:15:59ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-09-011310.3389/fonc.2023.12567601256760Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patientsBetina Børresen0Maja L. Arendt1Elise Konradsson2Kristine Bastholm Jensen3Sven ÅJ. Bäck4Per Munck af Rosenschöld5Crister Ceberg6Kristoffer Petersson7Kristoffer Petersson8Department of Veterinary Clinical Sciences, University of Copenhagen, Frederiksberg, DenmarkDepartment of Veterinary Clinical Sciences, University of Copenhagen, Frederiksberg, DenmarkMedical Radiation Physics, Department of Clinical Sciences, Lund University, Lund, SwedenVeterinärhuset Öresund, Limhamn, SwedenRadiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, SwedenRadiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, SwedenMedical Radiation Physics, Department of Clinical Sciences, Lund University, Lund, SwedenRadiation Physics, Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, SwedenDepartment of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United KingdomBackgroundFLASH radiotherapy (RT) is a novel method for delivering ionizing radiation, which has been shown in preclinical studies to have a normal tissue sparing effect and to maintain anticancer efficacy as compared to conventional RT. Treatment of head and neck tumors with conventional RT is commonly associated with severe toxicity, hence the normal tissue sparing effect of FLASH RT potentially makes it especially advantageous for treating oral tumors. In this work, the objective was to study the adverse effects of dogs with spontaneous oral tumors treated with FLASH RT.MethodsPrivately-owned dogs with macroscopic malignant tumors of the oral cavity were treated with a single fraction of ≥30Gy electron FLASH RT and subsequently followed for 12 months. A modified conventional linear accelerator was used to deliver the FLASH RT.ResultsEleven dogs were enrolled in this prospective study. High grade adverse effects were common, especially if bone was included in the treatment field. Four out of six dogs, who had bone in their treatment field and lived at least 5 months after RT, developed osteoradionecrosis at 3-12 months post treatment. The treatment was overall effective with 8/11 complete clinical responses and 3/11 partial responses.ConclusionThis study shows that single-fraction high dose FLASH RT was generally effective in this mixed group of malignant oral tumors, but the risk of osteoradionecrosis is a serious clinical concern. It is possible that the risk of osteonecrosis can be mitigated through fractionation and improved dose conformity, which needs to be addressed before moving forward with clinical trials in human cancer patients.https://www.frontiersin.org/articles/10.3389/fonc.2023.1256760/fullradiotherapyFLASH radiotherapyosteoradionecrosislate toxicitycanine cancertranslational research
spellingShingle Betina Børresen
Maja L. Arendt
Elise Konradsson
Kristine Bastholm Jensen
Sven ÅJ. Bäck
Per Munck af Rosenschöld
Crister Ceberg
Kristoffer Petersson
Kristoffer Petersson
Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
Frontiers in Oncology
radiotherapy
FLASH radiotherapy
osteoradionecrosis
late toxicity
canine cancer
translational research
title Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
title_full Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
title_fullStr Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
title_full_unstemmed Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
title_short Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
title_sort evaluation of single fraction high dose flash radiotherapy in a cohort of canine oral cancer patients
topic radiotherapy
FLASH radiotherapy
osteoradionecrosis
late toxicity
canine cancer
translational research
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1256760/full
work_keys_str_mv AT betinabørresen evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT majalarendt evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT elisekonradsson evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT kristinebastholmjensen evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT svenajback evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT permunckafrosenschold evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT cristerceberg evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT kristofferpetersson evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients
AT kristofferpetersson evaluationofsinglefractionhighdoseflashradiotherapyinacohortofcanineoralcancerpatients